Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yitzhar E. Goretsky"'
Autor:
Pavlina Chuntova, Kira Downey, Ryusuke Hatae, Tiffany A Chen, Abigail L Mende, Megan Montoya, Bjoern Schwer, Jayne Skinner, Hideho Okada, Gary Kohanbash, Takahide Nejo, Yitzhar E. Goretsky, Yafei Hou, Hong-Erh Liang, David Diebold, Akane Yamamichi, Ryosuke Naka
Publikováno v:
Neuro-oncology, vol 24, iss 2
Neuro Oncol
Neuro Oncol
Background Rigorous preclinical studies of chimeric antigen receptor (CAR) immunotherapy will require large quantities of consistent and high-quality CAR-transduced T (CART) cells that can be used in syngeneic mouse glioblastoma (GBM) models. To this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e413a9fb76c4ae0a30fdd3ad9738da0b
https://doi.org/10.1093/neuonc/noab182
https://doi.org/10.1093/neuonc/noab182
Autor:
Choe Joseph H, Anna Celli, Juhyun Cho, Kira Downey, Wei Yu, Olga G. Troyanskaya, Aileen W. Li, Diego Carrera, Ruth Dannenfelser, Yitzhar E. Goretsky, Kole T. Roybal, Jessica D. Briones, Sachdev S. Sidhu, Wendell A. Lim, Ryan Gilbert, Lia Cardarelli, Nira A. Krasnow, Milos S. Simic, Hideho Okada, Jason M. Duecker, Payal Watchmaker
Publikováno v:
Science translational medicine, vol 13, iss 591
Sci Transl Med
Sci Transl Med
Treatment of solid cancers with chimeric antigen receptor (CAR) T cells is plagued by the lack of ideal target antigens that are both absolutely tumor specific and homogeneously expressed. We show that multi-antigen prime-and-kill recognition circuit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b526cc204fad3a7a0516aa6cc3ee6df1
https://escholarship.org/uc/item/64p7w6f3
https://escholarship.org/uc/item/64p7w6f3
Autor:
Tiffany A Chen, David Diebold, Yitzhar E. Goretsky, Hideho Okada, Bjoern Schwer, Yafei Hou, Jayne Skinner, Hong-Erh Liang, Abigail L Mende, Ryosuke Naka, Pavlina Chuntova, Kira Downey, Megan Montoya, Gary Kohanbash, Takahide Nejo, Akane Yamamichi
BackgroundRigorous preclinical studies of chimeric antigen receptor (CAR) immunotherapy will require large quantities of consistent and high-quality CAR-transduced T (CART)-cells that can be used in syngeneic mouse glioblastoma (GBM) models. To this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b86bcff4afeb945f4ecee99fa7142dc
https://doi.org/10.1101/2021.01.31.429020
https://doi.org/10.1101/2021.01.31.429020
Publikováno v:
Seminars in Immunology. 47:101385
Immunotherapy applications to glioblastoma represent a new treatment frontier. Antigen-targeted immunotherapy approaches hold enormous potential to elicit antigen-specific anti-tumor effects in central nervous system tumors. Still, the paucity of eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e1ee8cbddfad7ef9d63406c513b680
https://doi.org/10.1016/j.smim.2020.101385
https://doi.org/10.1016/j.smim.2020.101385